

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.64030922 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.64030922 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.38098975 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.38098975 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.14245056 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.90379791 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.70422727 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.70422727 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.70422727 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.56650149 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.46109925 |
| 12 | urea cycle (GO:0000050) | 5.40997706 |
| 13 | urea metabolic process (GO:0019627) | 5.40997706 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.37778459 |
| 15 | complement activation, alternative pathway (GO:0006957) | 5.24440825 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.19165535 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.16687426 |
| 18 | protein carboxylation (GO:0018214) | 5.14500120 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.14500120 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.11936887 |
| 21 | cysteine metabolic process (GO:0006534) | 5.11232195 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.03146165 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.00870998 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.00569928 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.95927163 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86586722 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.79740529 |
| 28 | regulation of complement activation (GO:0030449) | 4.71607839 |
| 29 | exogenous drug catabolic process (GO:0042738) | 4.69019889 |
| 30 | bile acid metabolic process (GO:0008206) | 4.65848271 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 4.63647621 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.57174322 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.57073036 |
| 34 | serine family amino acid catabolic process (GO:0009071) | 4.56865393 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.55768922 |
| 36 | phospholipid efflux (GO:0033700) | 4.47503004 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.45313657 |
| 38 | plasma lipoprotein particle clearance (GO:0034381) | 4.43941078 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.43584589 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.43584589 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.43584589 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.34184136 |
| 43 | lysine metabolic process (GO:0006553) | 4.28888382 |
| 44 | lysine catabolic process (GO:0006554) | 4.28888382 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.23978610 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.23978610 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.23428524 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.14200584 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.14200584 |
| 50 | cholesterol efflux (GO:0033344) | 4.11745236 |
| 51 | alpha-amino acid catabolic process (GO:1901606) | 4.10628338 |
| 52 | bile acid and bile salt transport (GO:0015721) | 4.08896020 |
| 53 | phospholipid homeostasis (GO:0055091) | 4.03541526 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.01418594 |
| 55 | L-serine metabolic process (GO:0006563) | 4.00383647 |
| 56 | cellular glucuronidation (GO:0052695) | 3.99658987 |
| 57 | aldehyde catabolic process (GO:0046185) | 3.92405713 |
| 58 | plasma lipoprotein particle assembly (GO:0034377) | 3.92341442 |
| 59 | amine catabolic process (GO:0009310) | 3.90297250 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 3.90297250 |
| 61 | ethanol oxidation (GO:0006069) | 3.87858755 |
| 62 | coenzyme catabolic process (GO:0009109) | 3.84129430 |
| 63 | fibrinolysis (GO:0042730) | 3.83141029 |
| 64 | imidazole-containing compound metabolic process (GO:0052803) | 3.80364930 |
| 65 | glycine metabolic process (GO:0006544) | 3.79754911 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 3.78828713 |
| 67 | cellular ketone body metabolic process (GO:0046950) | 3.78427270 |
| 68 | cellular amino acid catabolic process (GO:0009063) | 3.77759830 |
| 69 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.75008144 |
| 70 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.75008144 |
| 71 | glutamate metabolic process (GO:0006536) | 3.74715313 |
| 72 | low-density lipoprotein particle remodeling (GO:0034374) | 3.73110149 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 3.71517054 |
| 74 | oxidative demethylation (GO:0070989) | 3.69577486 |
| 75 | arginine metabolic process (GO:0006525) | 3.68860097 |
| 76 | cellular modified amino acid catabolic process (GO:0042219) | 3.68707767 |
| 77 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.68149949 |
| 78 | positive regulation of lipid catabolic process (GO:0050996) | 3.66870591 |
| 79 | glucuronate metabolic process (GO:0019585) | 3.65234760 |
| 80 | uronic acid metabolic process (GO:0006063) | 3.65234760 |
| 81 | cholesterol homeostasis (GO:0042632) | 3.65207482 |
| 82 | sterol homeostasis (GO:0055092) | 3.60005426 |
| 83 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59428031 |
| 84 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.59259793 |
| 85 | protein-lipid complex assembly (GO:0065005) | 3.59239864 |
| 86 | drug catabolic process (GO:0042737) | 3.55939294 |
| 87 | cofactor catabolic process (GO:0051187) | 3.55419710 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 3.55141845 |
| 89 | complement activation (GO:0006956) | 3.52791927 |
| 90 | plasma lipoprotein particle organization (GO:0071827) | 3.52169810 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.51870970 |
| 92 | intestinal cholesterol absorption (GO:0030299) | 3.50861364 |
| 93 | protein activation cascade (GO:0072376) | 3.47707760 |
| 94 | lipoprotein metabolic process (GO:0042157) | 3.45687599 |
| 95 | serine family amino acid biosynthetic process (GO:0009070) | 3.42038760 |
| 96 | acute-phase response (GO:0006953) | 3.41675206 |
| 97 | acetyl-CoA metabolic process (GO:0006084) | 3.40158876 |
| 98 | tetrahydrofolate metabolic process (GO:0046653) | 3.40053717 |
| 99 | cytolysis (GO:0019835) | 3.37800186 |
| 100 | response to nitrosative stress (GO:0051409) | 3.36443082 |
| 101 | organic acid catabolic process (GO:0016054) | 3.36377439 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.36377439 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.36179170 |
| 104 | protein-lipid complex subunit organization (GO:0071825) | 3.35541257 |
| 105 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.32505773 |
| 106 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.32505773 |
| 107 | regulation of hippo signaling (GO:0035330) | 3.22811551 |
| 108 | epoxygenase P450 pathway (GO:0019373) | 3.20962169 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.20425341 |
| 110 | omega-hydroxylase P450 pathway (GO:0097267) | 3.16514119 |
| 111 | drug metabolic process (GO:0017144) | 3.16420899 |
| 112 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.15101334 |
| 113 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.10394015 |
| 114 | desmosome organization (GO:0002934) | 3.08886758 |
| 115 | drug transmembrane transport (GO:0006855) | 3.05898965 |
| 116 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.05560563 |
| 117 | methionine biosynthetic process (GO:0009086) | 3.05072618 |
| 118 | regulation of translational fidelity (GO:0006450) | 3.05016912 |
| 119 | response to pheromone (GO:0019236) | 3.02529045 |
| 120 | amino acid salvage (GO:0043102) | 3.00910781 |
| 121 | L-methionine salvage (GO:0071267) | 3.00910781 |
| 122 | L-methionine biosynthetic process (GO:0071265) | 3.00910781 |
| 123 | sulfur amino acid biosynthetic process (GO:0000097) | 3.00000854 |
| 124 | folic acid-containing compound metabolic process (GO:0006760) | 2.96794645 |
| 125 | polyketide metabolic process (GO:0030638) | 2.93398380 |
| 126 | doxorubicin metabolic process (GO:0044598) | 2.93398380 |
| 127 | daunorubicin metabolic process (GO:0044597) | 2.93398380 |
| 128 | hemidesmosome assembly (GO:0031581) | 2.92206092 |
| 129 | midgut development (GO:0007494) | 2.88105619 |
| 130 | S-adenosylmethionine metabolic process (GO:0046500) | 2.85846546 |
| 131 | DNA replication checkpoint (GO:0000076) | 2.81889684 |
| 132 | negative regulation of protein activation cascade (GO:2000258) | 2.81541860 |
| 133 | methionine metabolic process (GO:0006555) | 2.80850746 |
| 134 | intestinal absorption (GO:0050892) | 2.76842573 |
| 135 | pteridine-containing compound metabolic process (GO:0042558) | 2.76573937 |
| 136 | nuclear pore complex assembly (GO:0051292) | 2.73799109 |
| 137 | folic acid metabolic process (GO:0046655) | 2.72367976 |
| 138 | aspartate family amino acid metabolic process (GO:0009066) | 2.71233377 |
| 139 | proline biosynthetic process (GO:0006561) | 2.65987383 |
| 140 | meiotic chromosome segregation (GO:0045132) | 2.64973865 |
| 141 | nuclear pore organization (GO:0006999) | 2.61214327 |
| 142 | alpha-amino acid biosynthetic process (GO:1901607) | 2.61061272 |
| 143 | pseudouridine synthesis (GO:0001522) | 2.60281462 |
| 144 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.60171148 |
| 145 | tRNA aminoacylation for protein translation (GO:0006418) | 2.56971482 |
| 146 | sulfur amino acid metabolic process (GO:0000096) | 2.56791606 |
| 147 | biotin metabolic process (GO:0006768) | 2.56400312 |
| 148 | androgen biosynthetic process (GO:0006702) | 2.56105576 |
| 149 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.55678085 |
| 150 | negative regulation of complement activation (GO:0045916) | 2.55462025 |
| 151 | amino acid activation (GO:0043038) | 2.54261745 |
| 152 | tRNA aminoacylation (GO:0043039) | 2.54261745 |
| 153 | ketone body metabolic process (GO:1902224) | 2.53457260 |
| 154 | proline metabolic process (GO:0006560) | 2.53340457 |
| 155 | phenylpropanoid metabolic process (GO:0009698) | 2.52045600 |
| 156 | nucleotide-sugar metabolic process (GO:0009225) | 2.48248349 |
| 157 | maturation of 5.8S rRNA (GO:0000460) | 2.47593240 |
| 158 | ribosome biogenesis (GO:0042254) | 2.45786624 |
| 159 | regulation of plasminogen activation (GO:0010755) | 2.45503066 |
| 160 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.43283013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.44561764 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.49616145 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.15909221 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.86238832 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.47632868 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.64661379 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.60756376 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.45479279 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.54814413 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.48536421 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.81175135 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.67871457 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.55410789 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.52636688 |
| 15 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.28992938 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.27501859 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.22468230 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08804521 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07407223 |
| 20 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.03897833 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03315412 |
| 22 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.03041711 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.01479138 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.00240605 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.4499252 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.98528314 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92342392 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88291794 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.79357102 |
| 30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78344932 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77092288 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.73350928 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.66350356 |
| 34 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66099251 |
| 35 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.64939494 |
| 36 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.64414138 |
| 37 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.64275820 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.60154020 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.60147339 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54342558 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.54091046 |
| 42 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.52560192 |
| 43 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.52560192 |
| 44 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.52550920 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.50270842 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50065586 |
| 47 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48984571 |
| 48 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.48249643 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.48132190 |
| 50 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45669862 |
| 51 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.43438501 |
| 52 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.42447211 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39919029 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39258813 |
| 55 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.38797921 |
| 56 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.38724757 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35996551 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34584076 |
| 59 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34022340 |
| 60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33331620 |
| 61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32700572 |
| 62 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27971510 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.26751832 |
| 64 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.23997741 |
| 65 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.18238427 |
| 66 | ATF3_27146783_Chip-Seq_COLON_Human | 1.18214888 |
| 67 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13837069 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13520421 |
| 69 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13228606 |
| 70 | EWS_26573619_Chip-Seq_HEK293_Human | 1.12013533 |
| 71 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.11662411 |
| 72 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.11126007 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10250614 |
| 74 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06938772 |
| 75 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.06439485 |
| 76 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.04513573 |
| 77 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.04141226 |
| 78 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.03938552 |
| 79 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.03325257 |
| 80 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02976673 |
| 81 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02208415 |
| 82 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.02099285 |
| 83 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.02048041 |
| 84 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.01596011 |
| 85 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.00303985 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99939863 |
| 87 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99804264 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99224501 |
| 89 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99090212 |
| 90 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.99048437 |
| 91 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.98506556 |
| 92 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98428972 |
| 93 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98371655 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97788585 |
| 95 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.96949452 |
| 96 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.96142424 |
| 97 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95185089 |
| 98 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95058025 |
| 99 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.94777396 |
| 100 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.93753438 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.92688038 |
| 102 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.90828159 |
| 103 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90653858 |
| 104 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90083135 |
| 105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89825319 |
| 106 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89264055 |
| 107 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89085026 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88688111 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.88190351 |
| 110 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.87282527 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.86116092 |
| 112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85520488 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85071370 |
| 114 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.84840179 |
| 115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83698601 |
| 116 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83272472 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83272472 |
| 118 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82940933 |
| 119 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81825642 |
| 120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81138947 |
| 121 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80400785 |
| 122 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.79375345 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77873773 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77449486 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76820972 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75692144 |
| 127 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74739738 |
| 128 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73952747 |
| 129 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72342560 |
| 130 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.71301319 |
| 131 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.71152312 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70896076 |
| 133 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.70882967 |
| 134 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69875377 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69745524 |
| 136 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.67739972 |
| 137 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.67624797 |
| 138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.65951478 |
| 139 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.65809354 |
| 140 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65290858 |
| 141 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65162941 |
| 142 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.64609489 |
| 143 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63039802 |
| 144 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.62008055 |
| 145 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.61651773 |
| 146 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61203885 |
| 147 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60679541 |
| 148 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.60254240 |
| 149 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.59806355 |
| 150 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.59348926 |
| 151 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58806089 |
| 152 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.58280121 |
| 153 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58260482 |
| 154 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.58119002 |
| 155 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56745654 |
| 156 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.56006672 |
| 157 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.55971689 |
| 158 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.54572701 |
| 159 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54181032 |
| 160 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.54064763 |
| 161 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53457415 |
| 162 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52605147 |
| 163 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.51876578 |
| 164 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.51869097 |
| 165 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.51585764 |
| 166 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.51246260 |
| 167 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.50573776 |
| 168 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50296295 |
| 169 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.49545182 |
| 170 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.49435840 |
| 171 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49085778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.32715024 |
| 2 | MP0005360_urolithiasis | 7.06741853 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.58272920 |
| 4 | MP0005365_abnormal_bile_salt | 5.46336500 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.52484202 |
| 6 | MP0009840_abnormal_foam_cell | 3.73270191 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.72056330 |
| 8 | MP0003252_abnormal_bile_duct | 3.53962128 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.40601787 |
| 10 | MP0005083_abnormal_biliary_tract | 2.83269268 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.74081097 |
| 12 | MP0003941_abnormal_skin_development | 2.66574217 |
| 13 | MP0003195_calcinosis | 2.55840699 |
| 14 | MP0005332_abnormal_amino_acid | 2.48525510 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.41770903 |
| 16 | MP0003950_abnormal_plasma_membrane | 2.37072398 |
| 17 | MP0000609_abnormal_liver_physiology | 2.13268925 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.11766272 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.06962469 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.02547844 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.98216820 |
| 22 | MP0000579_abnormal_nail_morphology | 1.96283460 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.82135536 |
| 24 | MP0004272_abnormal_basement_membrane | 1.73940005 |
| 25 | MP0010094_abnormal_chromosome_stability | 1.65238589 |
| 26 | MP0004957_abnormal_blastocyst_morpholog | 1.61889591 |
| 27 | MP0004233_abnormal_muscle_weight | 1.61865922 |
| 28 | MP0010234_abnormal_vibrissa_follicle | 1.57907792 |
| 29 | MP0002938_white_spotting | 1.50759055 |
| 30 | MP0001764_abnormal_homeostasis | 1.50664811 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48832157 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.48157522 |
| 33 | MP0003436_decreased_susceptibility_to | 1.47030240 |
| 34 | MP0003868_abnormal_feces_composition | 1.45237838 |
| 35 | MP0010678_abnormal_skin_adnexa | 1.44258307 |
| 36 | MP0000427_abnormal_hair_cycle | 1.43857343 |
| 37 | MP0003186_abnormal_redox_activity | 1.40140409 |
| 38 | MP0009764_decreased_sensitivity_to | 1.39451843 |
| 39 | MP0000604_amyloidosis | 1.37370793 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.37300200 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.36192304 |
| 42 | MP0000647_abnormal_sebaceous_gland | 1.34412489 |
| 43 | MP0009697_abnormal_copulation | 1.32287544 |
| 44 | MP0003111_abnormal_nucleus_morphology | 1.31370833 |
| 45 | MP0002254_reproductive_system_inflammat | 1.31271321 |
| 46 | MP0005451_abnormal_body_composition | 1.31086449 |
| 47 | MP0009643_abnormal_urine_homeostasis | 1.29816236 |
| 48 | MP0002060_abnormal_skin_morphology | 1.28724743 |
| 49 | MP0008058_abnormal_DNA_repair | 1.27339582 |
| 50 | MP0008469_abnormal_protein_level | 1.23678702 |
| 51 | MP0000383_abnormal_hair_follicle | 1.23414962 |
| 52 | MP0003937_abnormal_limbs/digits/tail_de | 1.22461719 |
| 53 | MP0003011_delayed_dark_adaptation | 1.20475776 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.20112348 |
| 55 | MP0002160_abnormal_reproductive_system | 1.19761349 |
| 56 | MP0009763_increased_sensitivity_to | 1.19708438 |
| 57 | MP0000598_abnormal_liver_morphology | 1.19651527 |
| 58 | MP0006082_CNS_inflammation | 1.14757671 |
| 59 | MP0004043_abnormal_pH_regulation | 1.13832453 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.13019694 |
| 61 | MP0003786_premature_aging | 1.12994019 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.10187294 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.09281285 |
| 64 | MP0000467_abnormal_esophagus_morphology | 1.08266805 |
| 65 | MP0003724_increased_susceptibility_to | 1.07105697 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.06474749 |
| 67 | MP0000762_abnormal_tongue_morphology | 1.06283938 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.06253343 |
| 69 | MP0002234_abnormal_pharynx_morphology | 1.05960955 |
| 70 | MP0008932_abnormal_embryonic_tissue | 1.05850653 |
| 71 | MP0005501_abnormal_skin_physiology | 1.02458440 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 0.98846588 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 0.98534255 |
| 74 | MP0005171_absent_coat_pigmentation | 0.93657162 |
| 75 | MP0009785_altered_susceptibility_to | 0.93086949 |
| 76 | MP0000566_synostosis | 0.92805579 |
| 77 | MP0003077_abnormal_cell_cycle | 0.92593716 |
| 78 | MP0003690_abnormal_glial_cell | 0.92456047 |
| 79 | MP0005647_abnormal_sex_gland | 0.92340522 |
| 80 | MP0003303_peritoneal_inflammation | 0.90586860 |
| 81 | MP0009053_abnormal_anal_canal | 0.90461488 |
| 82 | MP0008872_abnormal_physiological_respon | 0.90298737 |
| 83 | MP0002419_abnormal_innate_immunity | 0.88985863 |
| 84 | MP0010771_integument_phenotype | 0.88596298 |
| 85 | MP0009642_abnormal_blood_homeostasis | 0.87375224 |
| 86 | MP0004147_increased_porphyrin_level | 0.84601728 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.84451925 |
| 88 | MP0009765_abnormal_xenobiotic_induced | 0.84317600 |
| 89 | MP0005408_hypopigmentation | 0.84001692 |
| 90 | MP0008007_abnormal_cellular_replicative | 0.82762623 |
| 91 | MP0004130_abnormal_muscle_cell | 0.82402881 |
| 92 | MP0010030_abnormal_orbit_morphology | 0.82110534 |
| 93 | MP0001216_abnormal_epidermal_layer | 0.81476793 |
| 94 | MP0003959_abnormal_lean_body | 0.81367537 |
| 95 | MP0006054_spinal_hemorrhage | 0.80392129 |
| 96 | MP0002796_impaired_skin_barrier | 0.80385668 |
| 97 | MP0003136_yellow_coat_color | 0.79844436 |
| 98 | MP0001835_abnormal_antigen_presentation | 0.78789837 |
| 99 | MP0004947_skin_inflammation | 0.77861489 |
| 100 | MP0003075_altered_response_to | 0.77624998 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 0.77232717 |
| 102 | MP0002971_abnormal_brown_adipose | 0.77186328 |
| 103 | MP0005025_abnormal_response_to | 0.76461505 |
| 104 | MP0000358_abnormal_cell_content/ | 0.76039503 |
| 105 | MP0001845_abnormal_inflammatory_respons | 0.75104897 |
| 106 | MP0000627_abnormal_mammary_gland | 0.74935681 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.74917647 |
| 108 | MP0000377_abnormal_hair_follicle | 0.74234421 |
| 109 | MP0002697_abnormal_eye_size | 0.74160699 |
| 110 | MP0001853_heart_inflammation | 0.74041398 |
| 111 | MP0005410_abnormal_fertilization | 0.73615739 |
| 112 | MP0005334_abnormal_fat_pad | 0.73168438 |
| 113 | MP0005166_decreased_susceptibility_to | 0.72678334 |
| 114 | MP0005670_abnormal_white_adipose | 0.71317988 |
| 115 | MP0003566_abnormal_cell_adhesion | 0.70862782 |
| 116 | MP0010368_abnormal_lymphatic_system | 0.69928149 |
| 117 | MP0010307_abnormal_tumor_latency | 0.69801993 |
| 118 | MP0005389_reproductive_system_phenotype | 0.69693360 |
| 119 | MP0000538_abnormal_urinary_bladder | 0.69666846 |
| 120 | MP0006035_abnormal_mitochondrial_morpho | 0.68408794 |
| 121 | MP0002111_abnormal_tail_morphology | 0.68171308 |
| 122 | MP0002078_abnormal_glucose_homeostasis | 0.68130386 |
| 123 | MP0003300_gastrointestinal_ulcer | 0.67396322 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.66408751 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.66260644 |
| 126 | MP0002136_abnormal_kidney_physiology | 0.65784488 |
| 127 | MP0000537_abnormal_urethra_morphology | 0.65546962 |
| 128 | MP0000639_abnormal_adrenal_gland | 0.64872193 |
| 129 | MP0001756_abnormal_urination | 0.64270246 |
| 130 | MP0004782_abnormal_surfactant_physiolog | 0.64180639 |
| 131 | MP0003699_abnormal_female_reproductive | 0.63971300 |
| 132 | MP0005167_abnormal_blood-brain_barrier | 0.63746974 |
| 133 | MP0002084_abnormal_developmental_patter | 0.63502198 |
| 134 | MP0005535_abnormal_body_temperature | 0.61880922 |
| 135 | MP0005197_abnormal_uvea_morphology | 0.61509962 |
| 136 | MP0003890_abnormal_embryonic-extraembry | 0.61152567 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.57076442 |
| 138 | MP0005084_abnormal_gallbladder_morpholo | 0.56637945 |
| 139 | MP0005164_abnormal_response_to | 0.56410771 |
| 140 | MP0000685_abnormal_immune_system | 0.55909881 |
| 141 | MP0005266_abnormal_metabolism | 0.54235433 |
| 142 | MP0005387_immune_system_phenotype | 0.54012746 |
| 143 | MP0001790_abnormal_immune_system | 0.54012746 |
| 144 | MP0003453_abnormal_keratinocyte_physiol | 0.53545416 |
| 145 | MP0000249_abnormal_blood_vessel | 0.53233014 |
| 146 | MP0005395_other_phenotype | 0.53015767 |
| 147 | MP0005448_abnormal_energy_balance | 0.52691476 |
| 148 | MP0005023_abnormal_wound_healing | 0.52443386 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.51272279 |
| 150 | MP0008873_increased_physiological_sensi | 0.51076639 |
| 151 | MP0009115_abnormal_fat_cell | 0.50215253 |
| 152 | MP0001881_abnormal_mammary_gland | 0.49711714 |
| 153 | MP0001800_abnormal_humoral_immune | 0.48603446 |
| 154 | MP0002876_abnormal_thyroid_physiology | 0.48409041 |
| 155 | MP0003329_amyloid_beta_deposits | 0.48168260 |
| 156 | MP0010155_abnormal_intestine_physiology | 0.47752674 |
| 157 | MP0004381_abnormal_hair_follicle | 0.46538302 |
| 158 | MP0001661_extended_life_span | 0.46141394 |
| 159 | MP0005000_abnormal_immune_tolerance | 0.45112767 |
| 160 | MP0002148_abnormal_hypersensitivity_rea | 0.44942617 |
| 161 | MP0003718_maternal_effect | 0.44524826 |
| 162 | MP0005220_abnormal_exocrine_pancreas | 0.44328914 |
| 163 | MP0008874_decreased_physiological_sensi | 0.43896146 |
| 164 | MP0002928_abnormal_bile_duct | 0.43788683 |
| 165 | MP0004883_abnormal_blood_vessel | 0.43704242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.72807461 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.63565431 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.41385548 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.00326536 |
| 5 | Xanthomatosis (HP:0000991) | 5.98746648 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.76167039 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.72334238 |
| 8 | Complement deficiency (HP:0004431) | 5.38314384 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.09132722 |
| 10 | Joint hemorrhage (HP:0005261) | 4.71153246 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.41592678 |
| 12 | Epidermoid cyst (HP:0200040) | 4.25490448 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.24917066 |
| 14 | Hyperammonemia (HP:0001987) | 4.16553558 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.15928956 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.12821815 |
| 17 | Abnormality of complement system (HP:0005339) | 4.07681505 |
| 18 | Fat malabsorption (HP:0002630) | 4.02345024 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.92545162 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.91931218 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.83530822 |
| 22 | Hyperglycinemia (HP:0002154) | 3.81596473 |
| 23 | Ketosis (HP:0001946) | 3.69547078 |
| 24 | Hypercholesterolemia (HP:0003124) | 3.68410876 |
| 25 | Hyperglycinuria (HP:0003108) | 3.65631763 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.62527317 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 3.60150261 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 3.56360661 |
| 29 | Myocardial infarction (HP:0001658) | 3.55657901 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.51960231 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.51960231 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.44784657 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.43524567 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 3.39210904 |
| 35 | Abnormality of alanine metabolism (HP:0010916) | 3.35088671 |
| 36 | Hyperalaninemia (HP:0003348) | 3.35088671 |
| 37 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.35088671 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.34213271 |
| 39 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.12122318 |
| 40 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.10900047 |
| 41 | Steatorrhea (HP:0002570) | 3.09867292 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.99180080 |
| 43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.90862985 |
| 44 | Birth length less than 3rd percentile (HP:0003561) | 2.90252710 |
| 45 | Hyperbilirubinemia (HP:0002904) | 2.85007676 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.80591488 |
| 47 | Chromsome breakage (HP:0040012) | 2.78642126 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.77007836 |
| 49 | Skin nodule (HP:0200036) | 2.75898409 |
| 50 | Glomerulonephritis (HP:0000099) | 2.74332421 |
| 51 | Esophageal varix (HP:0002040) | 2.65869772 |
| 52 | Spontaneous abortion (HP:0005268) | 2.63205003 |
| 53 | Ketoacidosis (HP:0001993) | 2.62986247 |
| 54 | Vascular calcification (HP:0004934) | 2.62271114 |
| 55 | Amyloidosis (HP:0011034) | 2.61469959 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.59882718 |
| 57 | Gingival bleeding (HP:0000225) | 2.57702494 |
| 58 | Delayed CNS myelination (HP:0002188) | 2.52505433 |
| 59 | Mitral stenosis (HP:0001718) | 2.46359300 |
| 60 | Metabolic acidosis (HP:0001942) | 2.46224282 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.42602117 |
| 62 | Spastic diplegia (HP:0001264) | 2.39905594 |
| 63 | Acanthocytosis (HP:0001927) | 2.36547499 |
| 64 | Hypoplasia of the pons (HP:0012110) | 2.33583861 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.32689373 |
| 66 | Abnormality of the pons (HP:0007361) | 2.29822446 |
| 67 | Menorrhagia (HP:0000132) | 2.27662384 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.27269949 |
| 69 | Cholelithiasis (HP:0001081) | 2.25313770 |
| 70 | Dicarboxylic aciduria (HP:0003215) | 2.25185629 |
| 71 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.25185629 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 2.22815338 |
| 73 | Cholecystitis (HP:0001082) | 2.22658594 |
| 74 | Abnormal gallbladder physiology (HP:0012438) | 2.22658594 |
| 75 | Malnutrition (HP:0004395) | 2.22278806 |
| 76 | Axonal loss (HP:0003447) | 2.21714960 |
| 77 | Hemorrhage of the eye (HP:0011885) | 2.21616622 |
| 78 | Abnormality of the nasal septum (HP:0000419) | 2.21578009 |
| 79 | Abnormality of proline metabolism (HP:0010907) | 2.21401739 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.21401739 |
| 81 | Pterygium (HP:0001059) | 2.20035799 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.19566955 |
| 83 | Nephritis (HP:0000123) | 2.19001796 |
| 84 | Lethargy (HP:0001254) | 2.17548057 |
| 85 | Gout (HP:0001997) | 2.16140921 |
| 86 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15322119 |
| 87 | Abnormal hair laboratory examination (HP:0003328) | 2.14050465 |
| 88 | Chorioretinal atrophy (HP:0000533) | 2.12795847 |
| 89 | Pancreatitis (HP:0001733) | 2.12308240 |
| 90 | Fair hair (HP:0002286) | 2.12197675 |
| 91 | Irritability (HP:0000737) | 2.11398776 |
| 92 | Thrombophlebitis (HP:0004418) | 2.09741685 |
| 93 | Breast hypoplasia (HP:0003187) | 2.06033443 |
| 94 | Upper motor neuron abnormality (HP:0002127) | 2.04580092 |
| 95 | Neonatal onset (HP:0003623) | 2.03913762 |
| 96 | Abnormality of glycolysis (HP:0004366) | 2.01530770 |
| 97 | Hypoglycemic seizures (HP:0002173) | 1.99501547 |
| 98 | Renal cortical cysts (HP:0000803) | 1.98880062 |
| 99 | Duplicated collecting system (HP:0000081) | 1.96841337 |
| 100 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96806537 |
| 101 | Abnormality of the renal cortex (HP:0011035) | 1.95619901 |
| 102 | Cerebellar dysplasia (HP:0007033) | 1.93431065 |
| 103 | Increased serum ferritin (HP:0003281) | 1.92655904 |
| 104 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.92548672 |
| 105 | Nausea (HP:0002018) | 1.91662150 |
| 106 | Increased serum pyruvate (HP:0003542) | 1.91252757 |
| 107 | Opisthotonus (HP:0002179) | 1.89958150 |
| 108 | Ureteral duplication (HP:0000073) | 1.89020723 |
| 109 | Type II lissencephaly (HP:0007260) | 1.88706082 |
| 110 | Enlarged kidneys (HP:0000105) | 1.88461641 |
| 111 | Pancreatic cysts (HP:0001737) | 1.87656705 |
| 112 | Alkalosis (HP:0001948) | 1.87400076 |
| 113 | Late onset (HP:0003584) | 1.87217766 |
| 114 | Vomiting (HP:0002013) | 1.86800506 |
| 115 | Congenital stationary night blindness (HP:0007642) | 1.86665416 |
| 116 | Brittle hair (HP:0002299) | 1.83313999 |
| 117 | Abnormality of the gallbladder (HP:0005264) | 1.82910629 |
| 118 | Abnormality of the preputium (HP:0100587) | 1.82392414 |
| 119 | Pulmonary embolism (HP:0002204) | 1.81682685 |
| 120 | Vacuolated lymphocytes (HP:0001922) | 1.81584500 |
| 121 | Autoimmune thrombocytopenia (HP:0001973) | 1.81074119 |
| 122 | Elevated alkaline phosphatase (HP:0003155) | 1.80885985 |
| 123 | Cerebral edema (HP:0002181) | 1.80568444 |
| 124 | Milia (HP:0001056) | 1.80314735 |
| 125 | Plantar hyperkeratosis (HP:0007556) | 1.80070493 |
| 126 | Brushfield spots (HP:0001088) | 1.79679300 |
| 127 | Generalized aminoaciduria (HP:0002909) | 1.79495910 |
| 128 | Partial agenesis of the corpus callosum (HP:0001338) | 1.78617098 |
| 129 | Abnormality of the carotid arteries (HP:0005344) | 1.77151154 |
| 130 | Reduced antithrombin III activity (HP:0001976) | 1.76617826 |
| 131 | Poikilocytosis (HP:0004447) | 1.76293527 |
| 132 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.76096267 |
| 133 | Hypertriglyceridemia (HP:0002155) | 1.76078202 |
| 134 | Abnormal cartilage morphology (HP:0002763) | 1.76031164 |
| 135 | Upper limb muscle weakness (HP:0003484) | 1.75871570 |
| 136 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.75403600 |
| 137 | Sparse eyelashes (HP:0000653) | 1.75363291 |
| 138 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.73992955 |
| 139 | Abnormality of homocysteine metabolism (HP:0010919) | 1.73016883 |
| 140 | Homocystinuria (HP:0002156) | 1.73016883 |
| 141 | Tubular atrophy (HP:0000092) | 1.72885516 |
| 142 | Alopecia of scalp (HP:0002293) | 1.70262128 |
| 143 | Progressive inability to walk (HP:0002505) | 1.69816235 |
| 144 | Natal tooth (HP:0000695) | 1.68362417 |
| 145 | Megaloblastic anemia (HP:0001889) | 1.67130599 |
| 146 | Meckel diverticulum (HP:0002245) | 1.66868398 |
| 147 | Glomerulosclerosis (HP:0000096) | 1.64740030 |
| 148 | Pendular nystagmus (HP:0012043) | 1.64588829 |
| 149 | Focal segmental glomerulosclerosis (HP:0000097) | 1.64469781 |
| 150 | Abnormality of the renal collecting system (HP:0004742) | 1.64295882 |
| 151 | Abnormality of the ileum (HP:0001549) | 1.64030664 |
| 152 | Popliteal pterygium (HP:0009756) | 1.61849940 |
| 153 | Redundant skin (HP:0001582) | 1.61298858 |
| 154 | Spastic paraparesis (HP:0002313) | 1.60180182 |
| 155 | Abnormality of vitamin metabolism (HP:0100508) | 1.59632139 |
| 156 | Paraparesis (HP:0002385) | 1.59221763 |
| 157 | Pancreatic fibrosis (HP:0100732) | 1.59153826 |
| 158 | Poikiloderma (HP:0001029) | 1.58985474 |
| 159 | Type I transferrin isoform profile (HP:0003642) | 1.57411663 |
| 160 | Generalized hypopigmentation of hair (HP:0011358) | 1.56922367 |
| 161 | Entropion (HP:0000621) | 1.56479387 |
| 162 | Abnormality of DNA repair (HP:0003254) | 1.55653440 |
| 163 | Decreased subcutaneous fat (HP:0001002) | 1.54081841 |
| 164 | Palmoplantar hyperkeratosis (HP:0000972) | 1.54040643 |
| 165 | Hypoplastic labia majora (HP:0000059) | 1.52799338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.68991300 |
| 2 | ERN1 | 4.54323713 |
| 3 | FGFR4 | 3.81156834 |
| 4 | SIK1 | 3.37552412 |
| 5 | ACVR1B | 3.23014997 |
| 6 | TAOK3 | 3.13798193 |
| 7 | EPHA2 | 2.95666002 |
| 8 | TYK2 | 2.74555880 |
| 9 | WNK4 | 2.67644423 |
| 10 | BMPR1B | 2.41029527 |
| 11 | TBK1 | 2.35407654 |
| 12 | ZAK | 2.34970741 |
| 13 | BUB1 | 2.34171191 |
| 14 | ERBB4 | 2.30341502 |
| 15 | TRIB3 | 2.15643713 |
| 16 | MAP3K14 | 2.13928934 |
| 17 | MST1R | 2.13214342 |
| 18 | BRSK2 | 2.09966711 |
| 19 | NEK1 | 2.06345804 |
| 20 | IRAK3 | 1.99961006 |
| 21 | EIF2AK1 | 1.99785723 |
| 22 | PKN2 | 1.99475489 |
| 23 | WEE1 | 1.89169753 |
| 24 | MST4 | 1.88682196 |
| 25 | STK39 | 1.87381167 |
| 26 | TTK | 1.86057698 |
| 27 | TSSK6 | 1.80300847 |
| 28 | EEF2K | 1.76284281 |
| 29 | PTK6 | 1.75819938 |
| 30 | INSRR | 1.75341097 |
| 31 | NEK9 | 1.75088343 |
| 32 | EIF2AK3 | 1.72757893 |
| 33 | JAK1 | 1.66158220 |
| 34 | MAPKAPK3 | 1.65048123 |
| 35 | EPHB1 | 1.60624932 |
| 36 | MAP2K3 | 1.59975780 |
| 37 | MAPK11 | 1.56761376 |
| 38 | STK38L | 1.56746304 |
| 39 | IKBKE | 1.51841610 |
| 40 | PDK2 | 1.49213122 |
| 41 | ICK | 1.46459692 |
| 42 | TLK1 | 1.43034189 |
| 43 | AKT3 | 1.39900375 |
| 44 | PIK3CG | 1.36973228 |
| 45 | JAK2 | 1.36396832 |
| 46 | ABL2 | 1.35691381 |
| 47 | MAPKAPK5 | 1.30840548 |
| 48 | KIT | 1.30390893 |
| 49 | NEK2 | 1.30190975 |
| 50 | MAP3K3 | 1.29649127 |
| 51 | MAP2K4 | 1.27600299 |
| 52 | LMTK2 | 1.23978829 |
| 53 | CSK | 1.23611662 |
| 54 | CDC7 | 1.22783186 |
| 55 | FLT3 | 1.22537993 |
| 56 | NME1 | 1.19820806 |
| 57 | TGFBR1 | 1.19687236 |
| 58 | GRK1 | 1.18960658 |
| 59 | FRK | 1.16028110 |
| 60 | CAMK1D | 1.15913857 |
| 61 | TGFBR2 | 1.12954237 |
| 62 | IRAK4 | 1.12837867 |
| 63 | RIPK1 | 1.12328861 |
| 64 | GRK6 | 1.12087426 |
| 65 | KDR | 1.09420280 |
| 66 | BLK | 1.06545548 |
| 67 | PRKAA2 | 1.06326102 |
| 68 | SRPK1 | 1.05022289 |
| 69 | MAP3K13 | 1.04900825 |
| 70 | MUSK | 1.02926864 |
| 71 | PLK3 | 1.02887773 |
| 72 | LATS1 | 1.01616684 |
| 73 | NUAK1 | 1.00731266 |
| 74 | DAPK2 | 1.00731244 |
| 75 | CHEK2 | 1.00608535 |
| 76 | MKNK2 | 1.00469257 |
| 77 | ADRBK2 | 0.99604956 |
| 78 | MAP4K1 | 0.99260279 |
| 79 | VRK2 | 0.96945942 |
| 80 | RPS6KB2 | 0.96808207 |
| 81 | CDK6 | 0.95017554 |
| 82 | MAP4K2 | 0.94523513 |
| 83 | PLK1 | 0.94137146 |
| 84 | OXSR1 | 0.92471767 |
| 85 | MAP3K12 | 0.90891231 |
| 86 | CSF1R | 0.88437004 |
| 87 | IKBKB | 0.87632742 |
| 88 | PBK | 0.86715364 |
| 89 | MKNK1 | 0.86597784 |
| 90 | JAK3 | 0.86207792 |
| 91 | EPHA3 | 0.85110825 |
| 92 | FGFR3 | 0.85039962 |
| 93 | MAP3K10 | 0.84594018 |
| 94 | MAP3K11 | 0.84178035 |
| 95 | BRSK1 | 0.83542676 |
| 96 | PAK4 | 0.81916349 |
| 97 | PRKCI | 0.81792703 |
| 98 | MAP3K7 | 0.79060790 |
| 99 | MELK | 0.77769516 |
| 100 | MAPK4 | 0.77404141 |
| 101 | CDK7 | 0.77192556 |
| 102 | CDK8 | 0.76497431 |
| 103 | ERBB3 | 0.76372571 |
| 104 | BMX | 0.75009633 |
| 105 | ZAP70 | 0.73289381 |
| 106 | PTK2 | 0.71891113 |
| 107 | TRIM28 | 0.71722264 |
| 108 | ERBB2 | 0.71633806 |
| 109 | PNCK | 0.70785438 |
| 110 | CHUK | 0.70726212 |
| 111 | PIM2 | 0.70278308 |
| 112 | AURKB | 0.69569605 |
| 113 | KSR2 | 0.67601636 |
| 114 | MAP3K5 | 0.67415828 |
| 115 | MET | 0.66998729 |
| 116 | PDPK1 | 0.66784263 |
| 117 | MAP3K6 | 0.64568747 |
| 118 | PLK4 | 0.61513267 |
| 119 | HCK | 0.60763982 |
| 120 | TAF1 | 0.60694185 |
| 121 | EGFR | 0.60651925 |
| 122 | GSK3A | 0.58464571 |
| 123 | TTN | 0.57667027 |
| 124 | SGK3 | 0.57632595 |
| 125 | DYRK1B | 0.56619127 |
| 126 | PRKACG | 0.56333514 |
| 127 | BTK | 0.55872688 |
| 128 | PRKCZ | 0.55581503 |
| 129 | EIF2AK2 | 0.54381153 |
| 130 | CSNK1G1 | 0.53749920 |
| 131 | MAPK12 | 0.52691675 |
| 132 | LATS2 | 0.52054009 |
| 133 | CAMK1G | 0.52049671 |
| 134 | CSNK1A1L | 0.52029984 |
| 135 | ABL1 | 0.51069116 |
| 136 | PDGFRA | 0.50949395 |
| 137 | ATR | 0.50875691 |
| 138 | PRKAA1 | 0.50158383 |
| 139 | FER | 0.50088936 |
| 140 | CSNK1G3 | 0.48762696 |
| 141 | RIPK4 | 0.48407321 |
| 142 | TRPM7 | 0.48384188 |
| 143 | MAP3K1 | 0.47326493 |
| 144 | ADRBK1 | 0.47083552 |
| 145 | MAP2K1 | 0.45756941 |
| 146 | PRKCQ | 0.45506833 |
| 147 | PIM1 | 0.45401756 |
| 148 | TIE1 | 0.45375707 |
| 149 | NTRK1 | 0.44845857 |
| 150 | WNK3 | 0.43703023 |
| 151 | ATM | 0.43265645 |
| 152 | CHEK1 | 0.43063758 |
| 153 | ITK | 0.42473908 |
| 154 | IGF1R | 0.42322414 |
| 155 | STK16 | 0.41584392 |
| 156 | RPS6KA5 | 0.41566339 |
| 157 | STK10 | 0.41221417 |
| 158 | PDK1 | 0.39272442 |
| 159 | STK3 | 0.39081270 |
| 160 | BCR | 0.38918136 |
| 161 | IRAK1 | 0.37721559 |
| 162 | MAP2K6 | 0.37279742 |
| 163 | MAP2K2 | 0.36564908 |
| 164 | VRK1 | 0.35748006 |
| 165 | AURKA | 0.35578335 |
| 166 | PRKCD | 0.35423864 |
| 167 | CSNK1E | 0.35338914 |
| 168 | SYK | 0.35279606 |
| 169 | MTOR | 0.34735330 |
| 170 | LYN | 0.34489912 |
| 171 | NME2 | 0.34175372 |
| 172 | RPS6KA4 | 0.33898235 |
| 173 | STK24 | 0.33364541 |
| 174 | MAP3K2 | 0.32954509 |
| 175 | MAP3K8 | 0.32686766 |
| 176 | CDK4 | 0.32259366 |
| 177 | PRKCE | 0.32259233 |
| 178 | FGFR2 | 0.32036615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.46068308 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.37799374 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36122112 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21929812 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02273496 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.88302470 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62838861 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45812637 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.42672782 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.38791417 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.37357632 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.33076802 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31957046 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.30633524 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26637450 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06810163 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06623470 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.02196014 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95365848 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94523631 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89549003 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89435333 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86718462 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75304942 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73800500 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71668906 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69888114 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68306121 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65980419 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49130660 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48900576 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47626881 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47298641 |
| 34 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.47012033 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.46109345 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.38908524 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37926585 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32619093 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27216489 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27032231 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.24979399 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.24350034 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.23917895 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22509316 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21853463 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18255811 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.14860913 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11877377 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05899888 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05705863 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03749252 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03117483 |
| 53 | Mismatch repair_Homo sapiens_hsa03430 | 0.97191741 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95360441 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 0.95015790 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93321146 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.92271772 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91640265 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 0.91134018 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89165396 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.87679920 |
| 62 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.87554146 |
| 63 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87463693 |
| 64 | Sulfur relay system_Homo sapiens_hsa04122 | 0.87353130 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85382660 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.83661496 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.79561623 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79438837 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.78886937 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78754380 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77636073 |
| 72 | Lysine degradation_Homo sapiens_hsa00310 | 0.76795971 |
| 73 | RNA transport_Homo sapiens_hsa03013 | 0.75871334 |
| 74 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.75851909 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75219583 |
| 76 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72983758 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71547707 |
| 78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70626824 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70531968 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70168642 |
| 81 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67167831 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.64605619 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64249659 |
| 84 | Protein export_Homo sapiens_hsa03060 | 0.60879322 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57613752 |
| 86 | RNA degradation_Homo sapiens_hsa03018 | 0.55771980 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.52525334 |
| 88 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50301881 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.50107697 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49981919 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49544278 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.48746443 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.48451961 |
| 94 | Base excision repair_Homo sapiens_hsa03410 | 0.46842255 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45137719 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.43414302 |
| 97 | Cell cycle_Homo sapiens_hsa04110 | 0.43337977 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42808315 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39771997 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39436561 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37383663 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.36814750 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36733939 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32406750 |
| 105 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.32002437 |
| 106 | Lysosome_Homo sapiens_hsa04142 | 0.25027893 |
| 107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22747808 |
| 108 | Pertussis_Homo sapiens_hsa05133 | 0.18941458 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18839216 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14806118 |
| 111 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.13082324 |
| 112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.12808320 |
| 113 | Leishmaniasis_Homo sapiens_hsa05140 | 0.12445003 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.08231035 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.07977116 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.06502078 |
| 117 | Legionellosis_Homo sapiens_hsa05134 | 0.04132207 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03146705 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.02915992 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01412198 |
| 121 | TNF signaling pathway_Homo sapiens_hsa04668 | -0.0735545 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0691973 |
| 123 | Influenza A_Homo sapiens_hsa05164 | -0.0529180 |
| 124 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0473560 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0406209 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | -0.0400180 |
| 127 | Osteoclast differentiation_Homo sapiens_hsa04380 | -0.0359703 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0274356 |
| 129 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | -0.0260996 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | -0.0031534 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0005495 |

